Jim Cramer says these 10 ‘old guard’ stocks are making a comeback

Jim Cramer says these 10 ‘old guard’ stocks are making a comeback


CNBC’s Jim Cramer on Tuesday offered investors a list of 10 companies that he believes are rising to the top as tech stocks collapse.

“It’s the revenge of the old guard right now, right here. All sorts of boring, conventional companies are taking back the market while the digitizers and disruptors are being burned,” he said.

Here is his list:

  1. Johnson & Johnson
  2. Eli Lilly
  3. Boeing
  4. Honeywell
  5. Raytheon
  6. Caterpillar
  7. Deere & Co
  8. PepsiCo
  9. Starbucks
  10. Nucor 

Cramer also warned that many investors refuse to embrace the “new reality” of the market’s distaste for tech stocks. He attributed the collapse of tech stocks largely to the plethora of competition in the industry.

Microsoft‘s Azure goes up against Amazon Web Services, which goes up against Google Cloud. Netflix now competes with half a dozen streaming services,” he said.

He added that the companies he mentioned are the opposite of tech firms struggling to differentiate themselves from industry peers: “Companies that don’t have much competition, or at least the competition’s so muted that it can’t disrupt the status quo.”

Disclaimer: Cramer’s Charitable Trust owns shares of Amazon, Alphabet, Johnson & Johnson, Eli Lilly, Honeywell, Microsoft and Starbucks.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Business

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat […]

Read More
Macy’s store revamp shows progress, but company expects sales to fall this year
Business

Macy’s store revamp shows progress, but company expects sales to fall this year

Macy’s on Wednesday beat Wall Street’s quarterly sales and profit expectations as its namesake brand showed signs of progress, yet still gave a cautious outlook for the year ahead. For the fiscal year, the company – which includes its namesake chain, higher-end department store Bloomingdale’s and beauty retailer Bluemercury – said it expects sales of […]

Read More
Disney embarks on new chapter as Josh D’Amaro takes over as CEO
Business

Disney embarks on new chapter as Josh D’Amaro takes over as CEO

Larissa Manoela and Josh D’Amaro, Chairperson of Walt Disney Parks and Resorts, wave to the audience after Panel Disney Experiences during Day 2 of the D23 Brazil: A Disney Experience at Transamerica Expo Center on November 09, 2024 in Sao Paulo, Brazil. Ricardo Moreira | Getty Images Disney is turning the page on a new […]

Read More